|
TFG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.12339043517795E-12 |
| Normal-vs-Stage2 |
1.880370E-03 |
| Normal-vs-Stage3 |
4.4174000000119E-06 |
| Normal-vs-Stage4 |
2.744300E-02 |
| Stage1-vs-Stage2 |
8.661000E-01 |
| Stage1-vs-Stage3 |
6.169900E-02 |
| Stage1-vs-Stage4 |
6.270600E-01 |
| Stage2-vs-Stage3 |
2.571200E-01 |
| Stage2-vs-Stage4 |
5.863800E-01 |
| Stage3-vs-Stage4 |
1.495230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.2683999994767E-07 |
| Normal-vs-Asian |
1.472560E-01 |
| Caucasian-vs-AfricanAmerican |
6.579000E-01 |
| Caucasian-vs-Asian |
9.821600E-01 |
| AfricanAmerican-vs-Asian |
8.651800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.77909909027107E-11 |
| Male-vs-Female |
2.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.27519999999037E-05 |
| Normal-vs-Extreme_Weight |
8.09989997296867E-09 |
| Normal-vs-Obese |
4.25159996098046E-09 |
| Normal-vs-Extreme_Obese |
7.237800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.290800E-01 |
| Normal_Weight-vs-Obese |
4.252000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.624200E-01 |
| Extreme_Weight-vs-Obese |
4.007200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.801200E-01 |
| Obese-vs-Extreme_Obese |
8.961200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.63950000000069E-05 |
| Normal-vs-Age(41-60Yrs) |
8.88178419700125E-16 |
| Normal-vs-Age(61-80Yrs) |
4.1784020687885E-11 |
| Normal-vs-Age(81-100Yrs) |
5.219400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.492410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.436400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.404100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.971700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.734200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.792600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.015590E-04 |
| Normal-VS-KIRP CIMP |
2.640900E-03 |
| Normal-VS-Unclassified PRCC |
3.0095999999924E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.963620E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.654400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.007600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.878140E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.720200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.608000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.85610000000125E-05 |
| Normal-vs-N1 |
5.81559999999204E-05 |
| Normal-vs-N2 |
7.294200E-01 |
| N0-vs-N1 |
1.453580E-02 |
| N0-vs-N2 |
3.530200E-01 |
| N1-vs-N2 |
1.052560E-01 |
|
|
